PropertyValue
?:definition
  • A preparation of allogeneic T-lymphocytes specific for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), obtained from convalescent donors who have recovered from Coronavirus disease 2019 (COVID-19), with immunomodulating activity against COVID-19. Upon administration of the SARS-CoV-2 specific T cells, these cells may recognize and kill SARS-CoV-2-infected cells.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C5420412_NCI>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C5420412_NCI>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all